Atlas Trials

Sequential Radiotherapy With CAR-T Cells in the Treatment of Relapsed and Refractory Hematological Malignancies With Extramedullary Lesions

Clinical trial NCT04790747 · UNKNOWN

Trial details

NCT number
NCT04790747
Sponsor
Zhejiang University
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Hematological Malignancies
Start date
2021-03-01
Primary completion
2024-03-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.